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Abstract. Okadaic acid and microcystin-LR, both po-
tent inhibitors of protein phosphatases (PP), blocked
vesicle fusion in a cell-free system. The effect of
okadaic acid was reversed by the purified catalytic
subunit of PP2A, but not PPl. Inhibition was gradual,
required Mg-ATP, and was reduced by protein kinase
inhibitors, indicating that it was mediated via protein
phosphorylation. A candidate protein kinase would be
cdc2 kinase, which normally is active in mitotic ex-
tracts and has been shown to inhibit endocytic vesicle
T
HE pathway of receptor-mediated endocytosis is used
by mammalian cells to internalize many macromole-
cules, including nutrients and polypeptide hormones
(Goldstein et al., 1985) . The transferrin cycle is one of the
most closely studied examples and provides a useful model
(Bleil and Bretscher, 1982 ; Hopkins and Trowbridge, 1983) .
Halotransferrin binds to cell surface receptors located in
clathrin-coated pits, which rapidly invaginate and pinch off
to form coated endocytic vesicles. After at least partial re-
moval of the clathrin coat (Rothman and Schmid, 1985),
transferrin is delivered to the endosome by a specific mem-
brane fusion event. Iron dissociates from transferrin in the
acidic environment of the endosome (Dautry-Varsat et al.,
1983 ; Klausner et al., 1983), and the apoprotein recycles to
the cell surface.
Although the transferrin cycle has been defined largely by
kinetic and morphological studies on intact cells, under-
standing of the molecular events that enable the receptor to
pass between endocytic compartments requires the reconsti-
tution of transport in cell-free systems. We have described
a cell-free assay for the specific fusion of endocytic vesicles
(Woodman and Warren, 1988, 1989) and this, together with
studies by others using different endocytic markers (Davey
et al ., 1985; for reviews see Warren et al., 1988; Gruenberg
and Howell, 1989), has defined broad requirements for vesi-
cle fusion. Fusion requires ATP and proteins on the vesicle
membranes, as well as cytosolic proteins. At least one of
these cytosolic proteins is inactivated by the alkylating agent
N-ethyl maleimide, and some evidence suggests that this is
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fusion (Tuomikoski, T., M .A. Felix, M. Dorée, and
J. Gruenberg. 1989. Nature (Lond.) . 342:942-945) .
However, it would appear that cdc2 kinase is not
responsible for inhibition by okadaic acid. When com-
pared to cytosol prepared from mitotic cells, okadaic
acid did not increase cdc2 kinase activity sufficiently
to account for the inhibition. In addition, inhibition
was maintained when cdc2 protein was depleted from
cytosol.
a protein also required for exocytic vesicle fusion (Diaz et
al., 1989). In addition, fusion is inhibited by nonhydrolyza-
ble analogues of GTP (Mayorga et al., 1989 ; Wessling-
Resnickand Braell, 1990), indicating a role for GTP-binding
proteins (Gorvel et al., 1991). Evidence that endocytic vesi-
cle fusion is regulated by protein phosphorylation was first
provided by Tuomikoski et al. (1989), who showed that cell-
free fusion was inhibited by partially purified starfish cdc2
kinase. This may be linked to the inhibition of endocytic
traffic that occurs during mitosis (Fawcett, 1965; Berlin et
al., 1978; Warren et al ., 1984; Sager et al., 1984), since
cdc2 kinase activity controls the entry ofthe cell into M-phase
(Nurse, 1990).
We have investigated further the regulation of endocytic
vesicle fusion by protein phosphorylation. However, rather
than add exogenous protein kinases to the fusion assay mix,
we have adopted a different approach. Phosphorylation of
proteins is generally controlled by a cycle of a kinase and op-
posing phosphatase (Cohen, 1989). Either activation of the
kinase or inhibition of the phosphatase will lead to hyper-
phosphorylation. We show here that specific phosphatase in-
hibitors, okadaic acid and microcystin, inhibit endocytic
vesicle fusion. Our results show that vesicle fusion in inter-
phase extracts is regulated by phosphorylation, and suggest
that a kinase distinct from cdc2 kinase is responsible.
Materials andMethods
Materials
All reagents, unless otherwise specified, wereobtained fromSigma Chemi-
cal Co. (St. Louis, MO), or BDH Chemicals Ltd. (Poole, UK). Okadaic
acid was a gift from Y Tsukitani (Fujisawa Pharmaceutical Co., Zbkyo, Ja-
pan) or bought from Moana Bioproducts Inc. (Honolulu, HI). It was stored
331in 10% DMSO at a final concentration of 1 mM and then diluted in water
to a IOx concentrate before use. Microcystin-LR was stored in water at
-20°C. Sheep antitransferrinantiserumwas obtained from theScottish An-
tibodyProduction Unit (Carluke, Scotland) . The kinaseinhibitor, 6'-dimeth-
ylaminopurine (6'-DMAP),' was stored at -20°C as a 50-mM stock in
water adjusted to pH 7.0 with NaOH. 5'p-Fluorosulfonylbenzoyl adenosine
(FSBA) was diluted from a 100-mM stock in DMSO.
Phosphatases
The catalytic subunits of type 1 and type 2A protein phosphatases (PPI and
PP2A) were prepared from rabbit skeletal muscle as described previously
(Cohen et al., 1988) and stored in 50% (vol/vol) glycerol at -20°C.
Radiolabeling
Human transferrin was radiolabeled with '251 to a specific activity of -107
cpm/pg exactly as described (Woodman and Warren, 1991).
Cells
A431 cells were maintained in DME supplemented with 10% (vol/vol)
FCS, 100 U/ml ofboth penicillin and streptomycin. Suspension HeLa cells
were grown in spinner flasks in MEM modified for suspension cultures
(Gibco Laboratories, Paisley, Scotland) and supplemented with 10% (vol/
vol) FCS, 100 U/ml of both penicillin and streptomycin, and nonessential
amino acids. Mitotic HeLa cells were preparedby growingcells inthe pres-
ence of the microtubule inhibitor nocodazole, which blocks the formation
of the mitotic spindle (Zieve et al., 1980). HeLa cells were resuspended
in fresh growth medium containing 0.1 pg/ml nocodazole (Boehringer
Mannheim-GmbH, Mannheim, Germany) to a concentration of 3 x 105
cells perml. After 24 hcells were harvestedby centrifugation. Mitotic indi-
ces were assessed by bis-benzamide (HOECHST dye 33258; Sigma Chemi-
cal Co., St. Louis, MO) staining of chromosomes; typically, a mitotic
index of >95% was achieved. Mitotic indices of unsynchronized cultures
were N4%.
Membrane Preparations
Donor and acceptor endocytic vesicles were prepared from cells to which
either 125I-transferrin or antitransferrin antibody was bound at 4°C, and
then internalized for 5 min at 37°C. Full details for the internalization of
ligands and preparation of membrane fractions are provided elsewhere
(Woodman and Warren, 1989, 1991).
Cytosol Preparations
Preparation of cytosol from A431 cells was as described elsewhere (Wood-
man and Warren, 1991). Cytosolswere desalted onBiogel P6columns (Bio-
Rad Laboratories, Cambridge, MA) into Hepes buffer (HB; 140 mM su-
crose, 70 mM potassium acetate, 20 mM Hepes, pH 7.2) containing 1 mM
DTT. Desalting was monitored using [3H]ATP (Amersham International,
Amersham, UK) and showed that x+90% of ATP was removed. HeLa
cytosol was prepared from parallel cultures ofunsynchronized and mitotic
cells. Cells (ti3 x 101 mitotic, 6 x 101 interphase, in 1 liter of growth
medium) were sedimented, resuspended in 150 mM KCI, 10 mM triethanol-
amine, pH 7.2, and left on ice for 10 min. After one wash in mitotic buffer
(MB; 50 mM KCI, 10 mM EGTA, 1.92 mM M9C12, 50 mM Hepes, pH
7.2) cells were resuspended in twice the volume of MB supplemented with
1 mM I)TT and protease inhibitors (1 Wg/ml chymostatin, 1 jug/ml pepstatin
A, 2 gg/ml E64, 1 Wg/ml antipain, 40 hg/ml PMSF). Cells were homog-
enized as for membrane preparations and the extracts were centrifuged at
400,000 g.~ for 30 min in a TLI00 bench-top ultracentrifuge (Beckman In-
struments Inc., Palo Alto, CA). Protein concentrations were typically 8-10
mg/ml (HeLa) and 5-7 mg/ml (A431). Cytosol was frozen and stored in liq-
uid nitrogen.
Fusion Assays
Assays for endocyticvesicle fusionwere carried out essentially asdescribed
(WoodmanandWarren, 1989), with the following modifications. Fora stan-
1. Abbreviations used in this paper: 6'-DMAP, 6'-dimethylaminopurine;
FSBA, 5'p-fluorosulfonylbenzoyl adenosine; HB, Hepes buffer; MB, mi-
totic buffer; PPI, PP2A, PP2B; type 1, 2A, and 2B protein phosphatases,
respectively.
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dard assay, cytosol (100 Ag) was made up to 20 Al with HB (A431) or MB
(HeLa) and added to 4 AI of an ATP-regenerating cocktail. Okadaic acid,
microcystin-LR, or control buffers (4 AI) were added and, unless otherwise
stated, incubated for 30 min at 37°C. Samples were returned to ice and do-
nor membranes (3 A1), unlabeled transferrin (2 Al of2 mg/ml inwater), and
acceptor membranes (7 Al) were added and then incubated for a further 2 h
at 37°C. Samples were diluted in ice-cold immunoprecipitation buffer
(0.1 M Tris-HCI, pH 8.0, 0.1 M NaC1, 5 MM M9C12, 1% [wt/vol] Triton
X-100, 0.5% [wt/vol] SDS, 1% [wt/vol] sodium deoxycholate, 0.1% BSA)
and processed exactly as described (Woodman and Warren, 1989). Each ex-
periment included a control sample, containing an ATPdepleting cocktail
of 50 mM glucose and 50 IU hexokinase (4 Al) . All results are means of
duplicate determinations.
Histone Kinase Assays
Cytosols were assayed for histone kinase activity following the method de-
scribed by LabM et al. (1989) with the following modifications. Cytosol
(5 Al at 1.0 mg/ml in the appropriate buffer: HB for A431 cytosol, MB for
HeLa cytosol; at this concentration, all extracts catalyzed incorporation of
phosphate from [-y"P]ATP into histones linearly over the time course of
the assay) was incubated with 15 pl ofassay mix (containing 50 kg histone
type Ills, 1 mM Mg-ATP, and 2 ACi [-y32P]ATP [Amersham International;
5,000 Ci/mmol]) for 15 min at 37°C; then labeled histones were precipi-
tated onto P81 phosphocellulose paper and washed extensively in 150 mM
H3PO4 to remove unincorporated radioactivity. Control samples without
histone were assayed and histone-dependent incorporation of [32P]phos-
phate was calculated by subtraction. SDS-PAGE analysis confirmed that
>90% of radioactivity was incorporated into histone (not shown).
Immunodepletion
Cdc2 kinase protein was depleted from A431 cytosol using a monoclonal
antibody raised against Xenopus cdc2, which cross-reacted with the mam-
malian protein. Hybridoma supernatant (40 ml) was passed several times
over a 0.4-ml protein A-Sepharose column. The column was washed exten-
sively in HB and unpacked. The beads were spun down and excess buffer
was removed with a syringe needle. Cytosol (300 Al) and an ATP-
regenerating cocktail (30 A1) were added, and the mixture was incubated
with occasional mixing for 90 min at roomtemperature before pelleting the
beads. A control cytosol sample was incubated with untreated protein
A-Sepharose beads equilibrated in HB.
Western BlotAnalysis
To assay for cdc2 protein or cyclin B, cytosol samples were run on 10%
polyacrylamide gels and transferred to nitrocellulose according to the
method of Towbin et al. (1979). Immunoblots using the monoclonal anti-
cdc2 antibody were visualized by incubating with 1251-protein A (1 ug/ml;
107 cpm/pg) and exposing to X-Omat AR-5 film (Eastman Kodak Co.,
Rochester, NY) . Blots were quantitated by counting each band for radioac-
tivity and subtracting a background value. Immunoblots using polyclonal
rabbit antisera were visualized with a horseradish peroxidase-conjugated
goat anti-rabbit antiserum (diluted 1:104), followed by treatment with the
enhanced chemiluminescence detection system (Amersham International)
and exposure to X-Omat AR-5 film.
Protein Assays
Protein concentrations were determined by the method ofBradford (1976) .
Results
Cellfree Fusion ofEndocytic Vesicles Is Blocked
by Phosphatase Inhibitors
Fusion of endocytic vesicles was monitored by an assay de-
scribedpreviously (Woodmanand Warren, 1988, 1989). Do-
nor endocytic vesicles, isolated from cells containing inter-
nalized '25I-transferrin, were mixed with acceptor endocytic
vesicles carrying internalized antitransferrin antibodies. In
the presence of MgATP and a cytosol fraction, vesicle fu-
sion occurred, andprecipitation ofthe resultingradiolabeled
332immunecomplex on Staphylococcus aureus cells gave an in-
direct measure of fusion . All results are expressed as the
ATPdependent immunoprecipitation of izsI-transferrin, af-
ter subtracting the signal obtained from incubations depleted
of ATP by hexokinase and glucose. For all experiments de-
scribed below the ATP-independent signal was <2 % of that
obtained from a complete incubation.
Okadaic acid and microcystin-LR, both potent inhibitors
of PP1 and PP2A (Bialojan and Takai, 1988 ; Haystead et al.,
1989; MacKintosh et al., 1990), inhibited vesicle fusion
markedly (Fig. 1). The maximum inhibition (90%) and ICso
(ti0.15 PM) of the two compounds were similar, suggesting
that they acted on the same site. Okadaic acid, when added
to 1 p,M at the end of the incubation at 37°C, did not reduce
the immunoprecipitation of issI-transferrin (not shown) in-
dicating that vesicle fusion itself was blocked, rather than the
generation of the signal . The ATP/(ADP + AMP) ratio,
measured by the method of Scott et al. (1977), remained at
>20:1 during the course of the incubation, confirming that
okadaic acid did not affect the ATPregenerating cocktail.
The ICso for the inhibition of fusion by okadaic acid and
microcystin-LR appears at first inconsistent with the much
higher affinities of the two inhibitors for the catalytic
subunits of PPl and PP2A (Cohen et al. , 1989; MacKintosh
et al., 1990). Okadaic acid has a K; for PPl of ti10 nM,
and for PP2A of<0.1 nM, whilethose ofmicrocystin-LR are
0.06 and <0.01 nM, respectively. It seemed likely that the ap-
parent ICso's were determined by the concentration of phos-
phatase, rather than the affinity of each inhibitor, and this
was confirmed when vesicle fusion was titrated against
okadaic acid at two cytosol concentrations (Fig. 2) . At 4.0
mg/ml cytosol, half-maximal inhibition was achieved at
N0.17 pM okadaic acid. A 10-fold decrease in cytosol con-
centration resulted in a 7-fold decrease in the ICso of
okadaic acid. This close correlation also suggests that the
majority of the relevant phosphatase(s) are cytosolic.
Okadaic acid acts rapidly, yet inhibition by okadaic acid
was not immediate (Fig. 3 A) . This is seen more easily if the
data are replotted to show the extent of inhibition at each
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Figure 1. Phosphatase inhibitors block cell-free fusion ofendocytic
vesicles. A431 cytosol was preincubated with 1 mM Mg-ATP and
okadaic or microcystin-LR for30 min at 37°C. Membranes and un-
labeled transferrin wereaddedand the incubation wascontinued for
a further 2 h before the extent of vesicle fusion was determined.
Concentrations refer to those in the final assay mix.
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Figure 2. Titerof okadaic acid depends on cytosol concentration.
Vesicle fusion was assayed at different concentrations of okadaic
acid using either0.4 or 4.0 mg/ml A431 cytosol. The concentration
of both okadaic acid and cytosol refers to the concentration in the
final assay mix. For clarity the results are normalized, and activity
in the absence of okadaic acid is expressed as 1001 in each case
(the extent of fusion at 0.4 mg/ml cytosol was 231 of that at 4.0
mg/ml cytosol) .
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Figure 3. Inhibition bY okadaic acid is time dependent. (A) Com-
plete fusion mixes were incubated for varying times at 37°C with
or without 1 ~,M okadaic acid, and the extent of vesicle fusion was
determined. Values are the average f SEM fromthree separate ex-
periments, each normalized (control incubation at 90 min = 100) .
(B) The data are expressed as the percent inhibitionby okadaic acid
at each time point. All samples were counted for 30 min.time point (Fig. 3 B ) . Inhibition was clearly time dependent,
with a t~ for inhibition of ti15-20 min. Furthermore, the
extent of inhibition was increased by preincubating cytosol
with okadaic acid and Mg-ATP at 37°C before addition of
membranes. In a typical experiment over 2 h, inhibition was
increased from 73 to 84 % . For this reason, unless otherwise
indicated, experiments included a 30-min preincubation of
cytosol with phosphatase inhibitors.
Inhibition by OkadaicAcidIsReversed
byPP2AButNot by PPI
To determine whichphosphatase is involved in the regulation
of vesicle fusion we attempted to reverse the inhibition by
adding purified catalytic subunits of PPl or PP2A. 0.2 ~,M
okadaic acid was added to cytosol, and then preincubated
with Mg-ATP for 30 min at 37°C. Catalytic subunits of PPl
or PP2A were added just before addition of membranes. Ad-
dition of N0.2 P.M PP2A increased activity above that seen
in the absence of inhibitor (Fig. 4). PPl did not restore fu-
sion, even when added at five times the concentration of
okadaic acid . A control experiment showed that the PPl
preparation was active (not shown). The stimulation of fu-
sion by PP2A in the absence of okadaic acid (31 %) was typi-
cal of that seen in several experiments.
PP2A could restore vesicle fusion after a complete assay
mix had been incubated with okadaic acid (Fig. 5), indicat-
ing that okadaic acid did not inhibit fusion simply by inac-
tivating the membranes. After 40 min, fusion was inhibited
by 85 % . A 1.5-fold molar excess of PP2A was added and,
after a lag, the rate of fusion rose to a level similar to that
of the untreated control, although the final extent of fusion
did not reach that found in the control incubation. Inhibition
couldalso be partially reversed by diluting the assay mix 10-
fold into fresh cytosol, indicating that endogenous phospha-
tases were capable of restoring activity (not shown).
okadaic
phosphatase acid
PP1 (1 NM)
PP1 (1 NM)
PP2A (0.2 NM)
PP2A (0.2 NM)
none
none
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Figure 4. Inhibition is reversed by PP2A but not PPI. A431 cytosol
was incubated with Mg-ATP, with or without 0.2 pM okadaic acid,
for 30 min at 37°C. Samples were returned to ice and catalytic
subunits of PPl or PP2A were added as indicated. After addition
of membranes, samples were incubated for a further 2 h at 37°C.
Concentrations refer to those in the final assay mix.
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Figure 5. Inhibition by okadaic acid can be partially reversed by
PP2A afterincubation of a complete assaymix. A431 cytosol was
preincubated with Mg-ATP, with or without okadaic acid (0.2 uM) ;
then membranes were added and the incubations continued for 40
min. PP2A (0.3 ~M) was added to one set ofsamples and the incu-
bations were continued as indicated.
InhibitionbyOkadaicAcidIsMediated
byaProteinKinase
The slow inhibition of vesicle fusion by okadaic acid sug-
gested that inhibition required the action of a protein kinase,
leading to hyperphosphorylation of a component of the fu-
sion reaction normally dephosphorylated by PP2A. Two
findings support this. Firstly, okadaic acid inhibited fusion
only in the presence of Mg-ATP (Fig. 6). Although incuba-
tions normally included 1 mM MgATP, added to desalted
cytosol, vesicle fusion occurred even at 20 ~,M added Mg-
ATP However, okadaic acid did not inhibit fusion below 100
500
aoo -
300
200
c N
100
0
0 20 40 60 80 100
time (min)
[Mg"ATP] (mM)
control
+okadaic acid
Figure 6. Inhibition by okadaic acid requires Mg-ATP A431
cytosol was incubated for 30 min at 37°C with or without okadaic
acid and the indicated concentration ofMg-ATP Membranes were
added with sufficient Mg-ATP to maintain the Mg-ATP concentra-
tion,and the incubationwas continued for 2 h. The fins] concentra-
tion of okadaic acid was 1 ~,M.
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hibitors reduce inhibition by
okadaic acid . A431 cytosol
was incubated with 50 jM
Mg-ATP and kinase inhibitors
as indicated for 15 min at 37°C.
Mg-ATP was added to 1 mM,
followed by okadaic acid (to
1 uM) or carrier DMSO (to
0.001%) . After a further 15
min at 37°C, membranes and
transferrin were added and the
incubation was continued for
0 a
￿
2 h . Inhibition by okadaic acid
was calculated at each con-
centration of kinase inhibitor .
FSBA did not affect control incubations at 2 mM . 6'-DMAP inhib-
ited fusion by 15 % at 5 mM . Inhibitor concentrations refer to those
during the preincubation .
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pM Mg-ATP, and inhibited fusion by94% at 1mM Mg-ATP.
Half-maximal inhibition was achieved at-200 p,M Mg-ATP
Secondly, inhibition by okadaic acid was reduced by the ki-
nase inhibitors FSBA (Colman, 1982) and 6 r-DMAP (Verde
et al., 1990) . Since these inhibitors compete with ATP,
cytosol was pretreated with inhibitor for 15 min at 37°C with
50 pM MgATP Then, okadaic acid and Mg-ATP (1 mM)
were added and the incubation was continued for a further
15 min before addition ofmembranes. 6r-DMAP (5 mM) re-
duced inhibition from 66 to 9 %, and FSBA (2 mM) reduced
inhibition from 68 to 23% (Fig . 7) . At these concentrations,
FSBA did not affect vesicle fusion itself, while 6 r-DMAP re-
duced fusion by only 15 % .
OkadaicAcidDoesNotIncrease
cdc2 Kinase Activity Sufficiently toAccount
forInhibition of VesicleFusion
Endocytic vesicle fusion is inhibited by starfish cyclin B-cdc2
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kinase (Tuomikoski et al ., 1989) and it was possible that
okadaic acid inhibited fusion via this kinase . To investigate
this further, we compared in the same experiment both cdc2
kinase activity, and the effect on endocytic vesicle fusion ac-
tivity of okadaic acid and of cytosol prepared from mitotic
cells . Cdc2 kinase activity was defined by the ability to trans-
fer phosphate from [y-"P]ATP to lysine-rich histones . For
each reaction the histone kinase assay was performed under
the same conditions as vesicle fusion, without other phos-
phatase inhibitors, so that the ability to incorporate
[,y-32p]
fromATP into histones could be compared directly with the
inhibition of vesicle fusion . Since it is difficult to generate
a preparation of mitotic A431 cells, this experiment used
cytosol from mitotic HeLa cells . Interphase and mitotic
cytosols were prepared from parallel cultures of cells .
Incubation mixes containing cytosol prepared from mi-
totic HeLa cells had histone kinase activity 6.3 times higher
than those containing interphase HeLa cytosol (Fig . 8 B) .
Levels of histone kinase were 4.8 times higher than inter-
phase levels even at the end of the incubation (not shown) .
This rise correlated with an increase in the level of cyclin B,
a component of active cdc2 kinase (Brizuela et al., 1989),
in the cytosol (Fig . 8 A) . Vesicle fusion was reduced by51%
when cytosol from interphase HeLa cells was substituted by
the same amount of cytosol prepared from mitotic cells . To
satisfy ourselves that inhibition was not merely a conse-
quence of microtubule disassembly caused by nocodazole
treatment of cells used to prepare mitotic cytosol we estab-
lished, firstly, that nocodazole did not affect fusion when
added directly to the assay at 1 p,g/ml and, secondly, that
cytosol prepared from cells incubated with nocodazole for
4 h instead of 24 h supported fusion as well as interphase
cytosol (not shown) .
In contrast, a concentration of okadaic acid that inhibited
vesicle fusion by 68% using HeLa cytosol gave only a 1.6-
fold increase in phosphorylation of histone over the control
incubation (Fig . 8 B) . No additional activation of cdc2 ki-
335
Figure 8 . Activation of cdc2
kinase by okadaic acid is not
sufficient to account for inhi-
bition of vesicle fusion . (A)
Cytosol (10 hg) from inter-
phase (lane 1) or mitotic HeLa
cells (lane 2) was analyzed for
cyclin B protein by Western
blot . The position of cyclin B
(p62) is indicated by the ar-
row. (B) Endocytic vesicle fu-
sion was measured using stan-
dard incubations and equal
concentrations of cytosol pre-
pared frommitoticHeLacells,
or interphase HeLa and A431
cells treated with or without
okadaic acid . Samples (equiv-
alent to 5 Fig cytosol) were
taken fromeach incubationmix
after addition of membranes,
and assayed for histone kinase
activity under the same buffer
conditions as the fusion assay.
All results are means ofdupli-
cates .Figure 9 . Depletion of cdc2 kinase does not affect inhibition by okadaic acid . (A) 20 Wg untreated A431 cytosol (lane 1) and cytosol treated
with either control (lane 2), or anti-cdc2 (lane 3) protein A-Sepharose beads, were analyzed by Western blotting using a polyclonal anti-
serum to show the relative concentration of cdc2 kinase protein in each . The position of cdc2 (p34) is indicated by the arrow. (B) Fusion
assays were performed using control or anti-cdc2 depleted cytosols in the presence or absence of 1 1M okadaic acid . Results are shown
from standard incubations, and from incubations where the 30-min preincubation of cytosol was omitted .
nase by okadaic acid occurred during the course ofthe fusion
incubation (not shown) .
These data suggested that activation of cdc2 kinase could
not account for the inhibition of fusion by okadaic acid in
HeLa cytosol . To be sure that cytosol from A431 cells be-
haved similarly, we also examined the ability ofokadaic acid
to increase cdc2 kinase activity in this system . Okadaic acid
at 1 pM inhibited vesicle fusion by 81%, yet increased his-
tone phosphorylation by only 1.6-fold (Fig . 8 B) .
Okadaic Acid Inhibits Fusion when Cytosol Is
Depleted ofcdc2Kinase Protein
Further evidence that okadaic acid inhibited endocytic vesi-
cle fusion independently of cdc2 kinase was provided by
depleting cytosol ofcdc2 protein using monoclonal antibod-
ies bound to Sepharose beads . Depletion was monitored by
Western blot analysis using a polyclonal antiserum raised to
a peptide from the COOH terminus of human cdc2 (Fig .
9 A) . In addition, quantitative immunoblotting using the
monoclonal antibody and 125I-protein A showed that 78% of
cdc2 protein was removed . When control and depleted
cytosols were assayed for fusion activity, with or without
preincubation of cytosol, it was found that okadaic acid in-
hibited fusion in cdc2-depleted cytosol to the same extent as
fusion in control cytosol (Fig . 9 B) .
Discussion
We have demonstrated that fusion of endocytic vesicles in a
cell-free system is inhibited markedly by two reagents,
okadaic acid, a C44 polyketal fatty acid, and microcystin-
LR, a cyclic heptapeptide . These structurally diverse re-
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agents show remarkable specificity for the catalytic subunits
ofPPl andMA, with amuch lower affinity for type2B pro-
tein phosphatases (Bialojan and Takai, 1988 ; MacKintosh et
al ., 1990) . Since they produce virtually identical inhibition
profiles we conclude that protein phosphatases play a key
role in regulating vesicle fusion . The effect of okadaic acid
can be reversed, either by addition ofexcess phosphatase or
by dilution into fresh cytosol, which indicates thatwe are not
observing a spurious inactivation ofmembranes . Inhibition
is completely prevented by inclusion ofthe purified catalytic
subunit ofMA, but not PPl. Whilewe cannot exclude the
possibility that the catalytic subunit of PPl remains inactive
because ofthe absence ofessential regulatory component(s),
it appears likely thatMA rather than PPl is critical for
regulation of vesicle fusion .
Our results are consistent with regulation of vesicle fusion
by phosphorylation of key component(s) of the fusion reac-
tion, where the degree of phosphorylation is controlled by
a system ofopposing protein kinase and phosphatase . Inhibi-
tion ofMA would result in hyperphosphorylation and inac-
tivation of these component(s) . This interpretation would
also explain the finding that addition of the catalytic subunit
ofMA actually stimulates vesicle fusion above control lev-
els . Evidence for the kinase is provided by the observations
that, firstly, okadaic acid does not inhibit at low MgATP
concentrations and, secondly, that protein kinase inhibitors
reduce the inhibition caused by okadaic acid . We cannot yet
exclude the possibility that okadaic acid also activates the ki-
nase to further increase phosphorylation .
It was previously reported that fusion ofendocytic vesicles
in Xenopus cytosols was inhibited by starfish cyclin B-cdc2
kinase (Tuomikoski et al., 1989) . Our data suggest that
336okadaic acid inhibits vesicle fusion via a protein kinase that
must be present, or activated by okadaic acid, in interphase
extracts. This would seem to exclude any role for cdc2 ki-
nase, which is active only in mitotic cell extracts. However,
we were concerned that a small proportion of cells in an un-
synchronized population are mitotic, resulting in low but
significant cdc2 kinase activity in these extracts. One might
arguethat with phosphatase activity abolishedthis kinase ac-
tivity would be sufficient to cause phosphorylation of a fu-
sion component. Furthermore, okadaic acid can promote
spontaneous and premature activation of cdc2 kinase in cy-
cling extracts from Xenopus eggs by inhibiting PP2A (Felix
et al., 1990) and causes a transient increase in cdc2 kinase
activity in BHK cells blocked in S phase (Yamashita et al.,
1990).
For these reasons we have compared the abilities of
okadaic acid and cdc2 kinase to inhibit fusion and phos-
phorylate histones. Histones can be used as a model for the
fusion component that is inactivated by phosphorylation,
since they are phosphorylated by cdc2 kinase and dephos-
phorylated by PPl and MA, and by cytosol in a manner pre-
vented by okadaic acid (Lee et al., 1990; Woodman, P G.,
and G. Warren, unpublished observations). We have shown
that cytosol prepared from cells blocked in mitosis by noco-
dazole contains elevated levels of cyclin B and cdc2 kinase
activity, consistent with the observation of Whitfield et al.
(1990). Furthermore, mitotic cytosol supports vesicle fusion
poorly, when compared with interphase cytosol. However,
when okadaic acid and mitotic cytosol were compared in the
same experimentfor theireffects on vesicle fusion and histone
phosphorylation, okadaic acid was foundto promote approxi-
mately four-fold less histone phosphorylation than mitotic
cytosol, yet inhibited fusion to a greater degree. This demon-
strates that okadaic acid does not activate cdc2 kinase sig-
nificantlyin extracts from unsynchronized cells and moreover
suggests that there is insufficient cdc2 kinase activity in these
extracts to account for the inhibition of fusion when phospha-
tases are blocked. Furthermore, depletion ofcdc2 kinase does
not substantially affect the inhibition by okadaic acid. Treat-
ment of interphase cytosols with an anti-cdc2 antibody re-
moved more than 78 ° ! o of the cdc2 protein but did not reduce
the inhibition of fusion by okadaic acid. Together, these results
suggest that okadaic acid inhibits fusion via a kinase other
than cdc2 kinase, though proof of this will require isolation
of the putative kinase.
The additional kinase could work downstream from cdc2
kinase to provide indirect regulation of vesicle fusion during
mitosis. Alternatively, vesicle fusion might be regulated dur-
ing interphase by protein phosphorylation. Okadaic acid also
inhibits fluid-phase endocytosis in intact interphase HeLa
cells (Lucocq, J., G. Warren, and J. Pryde. J. Cell Sci. In
press.) . There is evidence that phosphorylation of some
receptors determines their distribution within the cell. For
example, phosphorylation of the EGF receptor follows
ligand binding, and may cause receptor down regulation
(Whiteley and Glaser, 1986). There is little evidence to date
that the endocytic pathway as a whole is regulated. However,
the idea that cells have the ability to regulate the volume of
endocytic transport according to their growth requirements,
or in response to external stimuli, is attractive. For cycling
receptors, regulation offusion couldbe used as a mechanism
Woodman et al. Endocytic Fusion Is Inhibited by Okadaic Acid
ofcontrolling the number of receptors expressed on the cell
surface, which would regulate the uptake of certain ligands.
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